To date, the treatment of gastroesophageal reflux disease consists of lifestyle modifications, medical management through proton pump inhibitors or H2 receptor blockers, and for refractory cases, surgery. The gold standard for surgical interventions in the laparoscopic Nissen fundoplication. However, the procedure has a reported 26% recurrence of reflux symptoms as well as variability in technique among different surgeons. Major postoperative complaints following Nissen fundoplications include inability to belch, vomit, and increased bloating and flatulence. The Linx device, recently approved for human use in 2012, is a magnetic sphincter augmentation device placed at the gastroesophageal junction and functions as an expandable ring which restores pressure of the lower esophageal sphincter. The main postoperative complaint following Linx placement is early dysphagia, reported in up to 19% of patients, which usually resolves spontaneously or may require esophageal dilation. As new evidence is produced, this article aims at reviewing current literature comparing the Nissen fundoplication to Linx device placement and to determine the relevance of Linx placement in the contemporary treatment of reflux disease.